Epsilogen, announces £30.75 million of financing.
Epsilogen based at ARC West London
Financing led by Novartis Venture Fund and joined by new investors 3B Future Health Fund, British Patient Capital, Schroders Capital and Caribou Property alongside founding investor Epidarex Capital and ALSA Ventures have invested in Epsilogen, based at ARC West London.
